Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Identification of differential gene expression between intestinal and diffuse gastric cancer using cDNA microarray.

Chi-Ming Wu1, Yun-Shien Lee, Tzu-Hao Wang

  • 1Department of Biotechnology, Vanung University, Tao-Yuan, Taiwan.

Oncology Reports
|December 6, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Androgen receptor may promote tumor progression via TTF-1/EGFR pathway in metastatic nasopharyngeal carcinoma" [Translational Oncology, Volume 65, March 2026, 102670].

Translational oncology·2026
Same author

SSTR2-targeting therapy in EBV-positive and EBV-negative metastatic nasopharyngeal carcinoma.

American journal of cancer research·2026
Same author

Surgery alone achieves comparable survival to adjuvant therapy in T4aN0M0 gingival squamous cell carcinoma with clear surgical margins: A registry-based propensity-matched analysis.

Oral oncology·2026
Same author

Androgen receptor may promote tumor progression via TTF-1/EGFR pathway in metastatic nasopharyngeal carcinoma.

Translational oncology·2026
Same author

Pharmacokinetics, Optimal Dosages, and Withdrawal Time of Florfenicol in Cobia (Rachycentron canadum) After Oral Administration via Medicated Feed.

Journal of veterinary pharmacology and therapeutics·2026
Same author

Probiotic Enterococcus faecium NCIMB 10415 modulates florfenicol pharmacokinetics, withdrawal time, and hepatic CYP3A activity, potentially lowering antibiotic efficacy in Nile tilapia (Oreochromis niloticus).

Comparative biochemistry and physiology. Toxicology & pharmacology : CBP·2025

Gene expression profiling reveals distinct yet overlapping genetic pathways in intestinal-type gastric cancer (IGC) and diffuse-type gastric cancer (DGC). Both cancer types share common gene expression alterations, but also exhibit unique genetic profiles.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genomics

Background:

  • Gastric cancer (GC) is a heterogeneous disease with distinct histological subtypes, including intestinal-type gastric cancer (IGC) and diffuse-type gastric cancer (DGC).
  • Understanding the molecular differences and similarities between IGC and DGC is crucial for developing targeted therapies and improving patient outcomes.

Purpose of the Study:

  • To compare the gene expression profiles of intestinal-type gastric cancer (IGC) and diffuse-type gastric cancer (DGC).
  • To identify common and unique genetic alterations associated with each gastric cancer subtype.

Main Methods:

  • cDNA microarray analysis was performed on 12 paired IGC and 11 paired DGC specimens with their adjacent normal epithelial tissues.
  • Quantitative real-time PCR and immunohistochemical staining were used to validate microarray findings.

Related Experiment Videos

Main Results:

  • Twenty-seven genes were commonly overexpressed in both IGC and DGC, involved in transcription, DNA replication, mitosis, apoptosis, and mitochondrial function.
  • Twelve genes were commonly underexpressed in both subtypes, associated with cell adhesion, migration, organelle transport, and matrix metalloproteinase activity.
  • Nineteen genes were more overexpressed in DGC (e.g., ANXA1, CCL7, CCL8), while eight genes were more overexpressed in IGC (e.g., CLDN4).
  • Gene expression patterns significantly differed between IGC and DGC, as indicated by clustering dendrogram analysis.

Conclusions:

  • IGC and DGC exhibit distinct genetic pathways, despite sharing some common molecular alterations.
  • The identified differentially expressed genes provide potential biomarkers for distinguishing between IGC and DGC and may represent therapeutic targets.